Hemenway Trust CO LLC Gilead Sciences, Inc. Transaction History

Hemenway Trust CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$71.58 - $87.29 $476,007 - $580,478	6,650 New	6,650 $487,000
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $462,343 - $603,323	-7,637 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$71.28 - $78.92 $1.55 Million - $1.72 Million	-21,741 Reduced 74.0%	7,637 $590,000
Q2 2018 Jul 30, 2018	SELL	$64.88 - $75.68 $5,060 - $5,903	-78 Reduced 0.26%	29,378 $2.08 Million
Q1 2018 Apr 24, 2018	BUY	$72.84 - $88.8 $58,053 - $70,773	797 Added 2.78%	29,456 $2.22 Million
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $285,596 - $335,249	-4,014 Reduced 12.29%	28,659 $2.05 Million
Q3 2017 Oct 26, 2017	BUY	$72.11 - $85.47 $2.36 Million - $2.79 Million	32,673	32,673 $2.65 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Hemenway Trust CO LLC, based on Form 13F filings with the SEC.

Stay updated on Hemenway Trust CO LLC with notifications on news.